Akanksha Sanghvi | Health Professions | Best Review Article Award

Dr. Akanksha Sanghvi | Health Professions | Best Review Article Award

Oprava Aesthetics | India

Dr. Akanksha Sanghvi is a globally trained dermatologist, aesthetic physician, researcher, author, and medical innovator, renowned for her expertise in clinical dermatology, trichology, regenerative medicine, and anti-aging science. As the Founder and Medical Director of Oprava Aesthetics, Mumbai, she has established one of India’s most advanced centers integrating evidence-based dermatology with aesthetic and regenerative therapies. Her research contributions include publications in leading journals such as the Journal of the European Academy of Dermatology and Venereology and the International Journal of Dermatology, along with authorship in Springer’s Handbook of Cancer and Immunology. A certified peer reviewer for Elsevier and Wiley, she holds two patents for dermatological instruments, with two more pending. Dr. Sanghvi’s pioneering work in stem cell and exosome therapy bridges science and clinical innovation, focusing on hair regeneration, skin rejuvenation, and autism care. Through her NGO, ODE INDIA, she leads an AI-powered tele-dermatology initiative to extend specialized care to rural communities. Recognized as the “Best Young Cosmetic Dermatologist of India,” she continues to advance global standards in aesthetic and regenerative dermatology, merging medical excellence with compassion and social responsibility.

Profile : Orcid

Featured Publications

Sanghvi, A. R. (2020). COVID-19: An overview for dermatologists. International Journal of Dermatology.

Shah, A., & Makhecha, M. (2016). Pustular psoriasis of pregnancy with acrodermatitis continua of Hallopeau. Indian Journal of Dermatology.

Shah, A., & Safaya, A. (2013). Spina bifida manifesta: Tethered cord syndrome with pilonidal sinus in a 4-month-old baby. Journal of Neuroradiology.

Shah, A., & Safaya, A. (2012). Granulomatous slack skin disease: A review, in comparison with mycosis fungoides. Journal of the European Academy of Dermatology and Venereology.

Bingbing Wu | Health Professions | Best Researcher Award

Dr. Bingbing Wu | Health Professions | Best Researcher Award

Zhejiang University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits

Dr. Bingbing Wu began his academic journey with a strong foundation in biological sciences and technology, later advancing to doctoral studies in animal science at Zhejiang University. His early academic training provided him with a deep understanding of cellular biology, developmental processes, and molecular mechanisms, which later became central to his research in regenerative medicine and women’s health. These formative years not only shaped his scientific curiosity but also set the stage for his future contributions to stem cell biology and tissue regeneration.

Professional Endeavors

Following his doctoral studies, Dr. Wu pursued postdoctoral research at Zhejiang University School of Medicine and The First Affiliated Hospital of Zhejiang University, where he investigated the molecular underpinnings of tissue regeneration and gynecological diseases. His professional path led him to roles as a research assistant, full-time researcher, and later junior principal investigator at Zhejiang University’s International School of Medicine. Each role deepened his expertise in applying cutting-edge technologies to complex medical problems and allowed him to cultivate leadership in research.

Contributions and Research Focus

Dr. Wu’s research is centered on stem cell biology, regenerative medicine, and women’s reproductive health. His work investigates key stem cells involved in endometrial development and regeneration, along with the regulatory mechanisms driving their differentiation. He applies single-cell and spatial multi-omics technologies to unravel the pathological basis of diseases such as intrauterine adhesions and preeclampsia. By integrating organoid models, he has advanced understanding of maternal-fetal interface formation and disease mechanisms, providing novel insights into therapeutic approaches for obstetric and gynecological conditions.

Accolades and Recognition

Throughout his career, Dr. Wu has earned prestigious recognition through numerous competitive research grants. He has been a principal investigator on projects funded by the National Natural Science Foundation of China and the Zhejiang Province Key Projects, reflecting the national and regional confidence in his scientific leadership. His publications in respected international journals such as ACS Applied Materials & Interfaces, Stem Cell Reports, Cell Discovery, and NPJ Regenerative Medicine highlight his contributions to the advancement of regenerative medicine and biomedical science.

Impact and Influence

Dr. Wu’s work has had a significant impact on the field of regenerative medicine, particularly in women’s reproductive health. His studies have not only elucidated molecular pathways of tissue development but also provided translational potential for developing bioactive materials and therapeutic interventions. By combining experimental and computational approaches, he has expanded the scope of regenerative research, inspiring peers and contributing to the global understanding of complex gynecological disorders.

Legacy and Future Contributions

As a scientist committed to innovation, Dr. Wu continues to push the boundaries of regenerative biology. His current projects focus on human adult uterine cell atlases, endometrial tissue engineering, and the role of specific stromal and immune cell populations in tissue regeneration. With ongoing leadership in funded projects and collaborations, he is shaping a scientific legacy that bridges fundamental biology with clinical application. His future contributions are expected to bring new hope for women suffering from reproductive health disorders.

Publications


Article: Autologous platelet-rich plasma dual-network hydrogel promotes human endometrial regeneration
Authors: Xiao Chen, Chengcheng Zhu, Lu Wang, Jialing Deng, Zhuomin Wang, Xiaolin Wu, Haimin Tan, Yiyuan Qu, Bingbing Wu, Yu Li, Keren Cheng, Jian Xu
Journal: Acta Biomaterialia
Year: 2025


Article: Natural regeneration-inspired sequential delivery of synergistic growth factors for structural and functional endometrial regeneration
Authors: Cheng Zhang, Chengcheng Zhu, Xiao Chen, Xuzhi Chen, Di Zhang, Huafei Zhao, Junwen Zhang, Yu Zhang, Wanwan Xu, Xiaofeng Zhao, Yingying Hu, Wei Wei, Jian Xu, Yu Li, Bingbing Wu
Journal: Acta Biomaterialia
Year: 2025


Article: Reshaping the chromatin landscape in HUVECs from small-for-gestational-age newborns
Authors: Lingling Yan, Zhimin Zhou, Shengcai Chen, Xin Feng, Junwen Mao, Fang Luo, Jianfang Zhu, Xiuying Chen, Yingying Hu, Yuan Wang, Bingbing Wu, Lizhong Du, Chunlin Wang, Liang Gong, Yanfen Zhu
Journal: JCI Insight
Year: 2025


Article: Size- and Dose-Dependent Body-Wide Organ Transcriptomic Responses to Calcium Phosphate Nanomaterials
Authors: Yu Li, Wei Jiang, Nanfang Nie, Jiaqi Xu, Xiaozhao Wang, Junwen Zhang, Jiahuan Guan, Chengcheng Zhu, Cheng Zhang, Ying Gu, Xiaoyi Chen, Shasha Yao, Zi Yin, Bingbing Wu*, Hongwei Ouyang*, Xiaohui Zou*
Journal: ACS Applied Materials & Interfaces
Year: 2023


Article: A Dual-Crosslinked Hydrogel Based on Gelatin Methacryloyl and Sulfhydrylated Chitosan for Promoting Wound Healing
Authors: Shunxian Ji, Yushuang Zhao, Xinrang Zhai, Lu Wang, Huali Luo, Zhiyong Xu, Wei Dong, Bingbing Wu*, Wei Wei*
Journal: International Journal of Molecular Sciences
Year: 2023


Conclusion

Dr. Bingbing Wu stands as a distinguished researcher whose academic dedication, professional achievements, and scientific contributions have left a lasting mark on regenerative medicine. His focus on stem cells, multi-omics, and endometrial regeneration has advanced both theoretical knowledge and applied therapeutic strategies. With continued research, mentorship, and innovation, he is poised to expand his influence further, leaving a legacy of discovery and practical impact in the field of health professions.

Yunlong Wang | Medicine and Dentistry | Best Researcher Award

Prof. Yunlong Wang | Medicine and Dentistry | Best Researcher Award

Beijing Anzhen Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Yunlong Wang began his illustrious academic journey at the prestigious Peking University Health Science Center, where he earned his Doctor of Cardiology (M.D.). Driven by an unwavering passion for cardiac sciences, he later expanded his expertise internationally through visiting scholar roles at Asklepios St. Georg Hospital, University of Chicago Hospital, and the Hospital of the University of Pennsylvania , specializing in electrophysiology. These experiences provided a robust foundation for his future contributions to cardiac arrhythmia treatment.

Professional Endeavors

Prof. Wang has been a cornerstone of Beijing Anzhen Hospital, Capital Medical University since 2007. As the Chief Physician and Executive Director of the Arrhythmias Ward Three, he oversees the department’s advanced cardiac electrophysiology operations. With unmatched skill, he performs over 1400 tachyarrhythmia radiofrequency ablation procedures annually. In addition to his clinical duties, he is a respected doctoral supervisor, educator for undergraduate medical students, and a key figure in national cardiovascular intervention training programs authorized by China’s National Health Commission.

Contributions and Research Focus

Prof. Wang’s clinical expertise centers on the diagnosis and radiofrequency ablation treatment of complex tachyarrhythmias such as persistent atrial fibrillation, premature ventricular contractions, and ventricular tachycardia. His research portfolio includes pivotal studies in both basic and clinical science. His fundamental research has been supported by the National Natural Science Foundation of China, examining the roles of CRT and the HIF-1α-Nkx2.5 axis in cardiac remodeling and ion channel regulation. His clinical investigations have significantly advanced understanding and treatment of arrhythmias, with more than ten SCI-indexed papers published as lead or corresponding author in the last five years.

Accolades and Recognition

Prof. Wang is a prominent member of several key professional bodies, including the National Committee of the Chinese Society of Biomedical Engineering (Electrocardiogram Technology Branch), and serves on the youth committees of the Heart Rhythm Branch and Beijing Medical Association. His scholarly contributions have been featured in high-impact journals such as Heart Rhythm, Europace, and J Cardiovasc Electrophysiol, affirming his stature in the field of cardiac electrophysiology.

Impact and Influence

Prof. Wang's leadership in arrhythmia treatment has redefined procedural benchmarks across China. By educating the next generation of cardiologists and shaping national training protocols, his influence permeates both clinical and academic spheres. His pioneering research in radiofrequency ablation and cardiac electrophysiology continues to inform best practices globally.

Legacy and Future Contributions

Prof. Wang’s legacy is built on a blend of surgical excellence, scientific inquiry, and educational mentorship. As cardiac electrophysiology continues to evolve, his ongoing research into molecular pathways and ablation techniques is poised to unlock new treatment paradigms. With a steadfast commitment to innovation and clinical precision, he remains a vital contributor to the future of cardiovascular medicine in China and beyond.

 

Publications


The mC2HEST Score for Incident Atrial Fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis)

  • Authors: Yanguang Li, Qiaoyuan Li, Lili Wang, Tao Zhang, Hai Gao, Daniele Pastori, Zhuo Liang, Gregory Y.H. Lip, Yunlong Wang

  • Journal: JACC: Advances

  • Year: 2025


Left atrial size and echocardiographic diastolic parameters as predictors of incident atrial fibrillation in older hospitalized patients

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: Aging Clinical and Experimental Research

  • Year: 2025


Atrial fibrillation phenotypes identified through cluster analysis in the CABANA study

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: International Journal of Cardiology

  • Year: 2025


Prompt Identification of the Location of Gap Conduction in the Mitral Isthmus Following Vein of Marshall Ethanol Infusion and Endocardial Ablation

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: Circulation: Arrhythmia and Electrophysiology

  • Year: 2025


Downregulation of SENP1 impairs nuclear condensation of MEF2C and deteriorates ischemic cardiomyopathy

  • Authors: Ying Xie, Qiaoyuan Li, Xiyun Bian, Yan Yin, Zhuo Liang, Xu Liu, Tao Zhang, Xiaozhi Liu, Xin Quan, Yunlong Wang

  • Journal: Clinical and Translational Medicine (Wiley)

  • Year: 2025


 

Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Ningxia Center for Disease Control and Prevention | China

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Prof. Dr. Wu Zhonglan's academic journey is marked by excellence and global engagement. Currently pursuing her PhD in Pathogen and Host Immunology, she laid a strong foundation with earlier distinctions that shaped her scientific career. Her selection for the National Scholarship enabled a year of advanced study at the QIMR Berghofer Medical Research Institute in Australia (2017–2018), reflecting both national confidence and international potential in her research acumen.

💼 Professional Endeavors

Prof. Wu serves as Chief of the Virus Section at the CDC and a Postgraduate Supervisor at Ningxia Medical University, underscoring her pivotal role in both research and mentorship. She holds influential appointments across national committees, including:

  •  ➤ Director, National AIDS Prevention and Control Association

  •  ➤ Member, National AIDS Testing Committee

  •  ➤ Member, National Microbial Sequencing Technical Committee

  •  ➤ Member, Ningxia Immunology Society

  •  ➤ Editorial Board Member, Journal of Phenomics

Her leadership spans laboratory diagnostics, public health strategy, and national policy.

🔬 Contributions and Research Focus

Prof. Wu’s scientific contributions are rooted in two major domains:

🦠 Viral Pathogen Research:
She has been at the forefront of utilizing Next-Generation Sequencing (NGS) technology for viral traceability—particularly for COVID-19 and monkeypox. Her innovative development of rapid screening platforms for unexplained pneumonia pathogens has strengthened epidemic preparedness and public health surveillance.

🧬 AIDS Molecular Epidemiology:
Prof. Wu is a key figure in HIV research in China. Her work involves constructing molecular transmission networks, analyzing HIV drug resistance, and refining HIV-RNA and HIV-DNA diagnostic technologies for improved treatment strategies and epidemiological tracing. She has successfully led 8 major research projects funded by the Natural Science Foundationreturnee innovation grants, and key R&D initiatives in Ningxia.

🏆 Accolades and Recognition

Prof. Wu has garnered widespread acclaim, including:

  •  ➤ National Public Health Leading Talent Program (2024)

  •  ➤ “Advanced Worker” of the Autonomous Region (2025)

  •  ➤ Ningxia Young Top Talent Cultivation Program (2017)

Her team’s achievements have been celebrated with:

  •  ➤ Third Prize for Scientific and Technological Progress (2019, 2023)

  •  ➤ Second Prize and two Third Prizes of the Ningxia Medical Science and Technology Awards

🌍 Impact and Influence

Through her pioneering work in pathogen genomics and HIV epidemiology, Prof. Wu has enhanced both regional and national capacities in disease control. Her influence extends into policy-making, health strategy design, and next-generation diagnostics. She is a role model for women in science, especially in traditionally male-dominated public health and molecular virology sectors.

📚 Legacy and Future Contributions

Prof. Wu has authored over 60 high-impact publications, with 14 SCI-indexed papers—one boasting an impact factor of 11.39. More than 10 papers have earned Outstanding Paper Awards in Ningxia, reflecting her consistent excellence in scientific communication. Looking ahead, Prof. Wu is poised to further shape China’s viral disease research landscape through integrative genomics, real-time diagnostics, and transdisciplinary collaborations. Her legacy will be defined not only by her discoveries but by the generations of researchers she continues to inspire.

Publications


📄  Sequencing of One Unique Recombinant CRF85_BC/CRF01_AE Genome and Two Partial Genomes from Ningxia, China

Authors: Li Y, Pei J, Zhu X, Liu Y, Ma X, Yang D, Wu Z
Journal: Viruses
Year: 2025


📄  HIV-1 Drug Resistance and Genetic Transmission Networks Among Patients with Sexually Transmitted HIV in Ningxia, China

Authors: Pei J, Wu Z, Si B, Ma C, Liu Y, Ma X, Kuai W, Zhang Y, Li Y
Journal: Frontiers in Public Health
Year: 2025


📄  Epidemiological and Spatial Analysis of Newly Diagnosed HIV-1/AIDS Patients Before Antiretroviral Therapy in Ningxia from 2020 to 2021

Authors: Liu Y, Ma X, Pei J, Yang D, Li Y, Zhu X, Wu Z
Journal: PLOS ONE
Year: 2025


📄  Epidemiological and Spatiotemporal Analysis of Elderly HIV-1/AIDS Patients in Ningxia, China, from 2018 to 2023

Authors: Wu Z, Liu Y, Ma X, Li Y, Zhu X, Yang D, Pei J, Li Y
Journal: Scientific Reports
Year: 2025


📄  Molecular Epidemiology of Hepatitis C Infections in Ningxia, China: Genotype, Phylogeny and Mutation Analysis

Authors: Wu Z, Cui L, Zhao W, Yang D, Chen H, Wang R, Wang X, Zhang L, He T
Journal: Virology Journal
Year: 2016


Hangyu Gu | Medicine and Dentistry | Best Researcher Award

Dr. Hangyu Gu | Medicine and Dentistry | Best Researcher Award

Beijing Jishuitan Hospital | China

Author Profile

Orcid

🎓 Early Academic Pursuits

Dr. Hangyu Gu embarked on his journey in medicine at the prestigious Peking University, where he earned his Bachelor’s Degree in Medicine between September 2004 and July 2010. Demonstrating a clear commitment to clinical excellence, he pursued further specialization and obtained his Medical Doctor’s Degree from the same institution by July 2012. His early academic years laid a strong foundation in medical science and surgical disciplines, setting the tone for a career deeply rooted in evidence-based practice and patient-centered care.

🏥 Professional Endeavors

Dr. Gu began his clinical practice as an intern at the No.2 Affiliated Hospital of Peking University from March 2010 to July 2011. He quickly advanced to become a resident in surgery at the same hospital, gaining invaluable experience in surgical protocols and trauma care. From August 2012 to April 2018, he served as an orthopedic fellow at the renowned Beijing Jishuitan Hospital, affiliated with Peking University’s Fourth Medical College. Since May 2018, he has been serving as an attending physician in the Department of Orthopedics and Traumatology at the same institution, where his clinical and surgical expertise continues to grow.

🔬 Contributions and Research Focus

Dr. Gu’s research interests focus primarily on orthopedic surgery, trauma recovery, and post-surgical outcomes in elderly patients. In 2022, he co-authored a study titled “Combination of Cable Cerclage and Hook Plate for the Fixation of Comminuted Fractures of Inferior Patellar Pole,” published in Orthopaedic Surgery, which reviewed the outcomes of 16 patients followed up for a year. In 2023, he contributed to groundbreaking research on femoral neck fractures, identifying how complete posterior cortex fractures increase the risk of avascular necrosis in elderly patients—published in the Chinese Medical Journal.

🏆 Accolades and Recognition

While formal awards are not listed, Dr. Gu's continuous appointment and academic contributions at one of China's top orthopedic institutions speak volumes about his professional esteem and peer recognition. His publication in internationally recognized journals reflects the impact and credibility of his research within the orthopedic community.

🌍 Impact and Influence

Dr. Gu's work significantly influences clinical decisions in orthopedic trauma management, especially for aging populations—a demographic increasingly prone to hip and knee fractures. His research contributes to improved surgical techniques and enhanced patient outcomes, guiding surgeons worldwide in managing complex cases with precision and care.

🔮 Legacy and Future Contributions

With an impressive blend of clinical experience and academic rigor, Dr. Hangyu Gu is poised to make lasting contributions to orthopedic innovation and surgical education. As he continues to publish and mentor, his influence will likely shape future best practices in fracture fixation and geriatric trauma care, advancing both national and global orthopedic standards.

Publications


📝 A Comparative Finite Element Study of Novel Design Hook Plates for Fixation of Patella Fracture

Authors: Cunxiang Ma, Jingyu Pan, Teng Zhang, Junqiang Wang, Wei Han, Hangyu Gu
Journal: Injury
Year: 2025


📝 Combination of Cable Cerclage and Hook Plate for the Fixation of Comminuted Fractures of Inferior Patellar Pole: A Review of 16 Consecutive Patients Followed Up for a Minimum of 1 Year

Authors: Hangyu Gu, Shiwen Zhu, Ting Li, Xinbao Wu
Journal: Orthopaedic Surgery
Year: 2022


📝 Complete Fracture of Posterior Cortex Increases the Risk of Avascular Necrosis After Osteosynthesis for Non-Displaced Femoral Neck Fractures in Elderly Patients

Authors: Hangyu Gu, Qianqian Wang, Minghui Yang, Xinbao Wu, Faming Tian, Shiwen Zhu
Journal: Chinese Medical Journal
Year: 2023


Kalei Hering | Medicine and Dentistry | Best Researcher Award

Dr. Kalei Hering | Medicine and Dentistry | Best Researcher Award

Harvard Medical School | United States

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Kalei Hering’s academic journey began at the United States Military Academy at West Point, where she majored in Life Sciences with honors, following a pre-medical and nuclear engineering track. As a Barry Goldwater Scholar and Rhodes Scholar Finalist, her undergraduate years were marked by distinction and ambition. She then advanced to Harvard Medical School, where she pursued her M.D. with exceptional performance, scoring a 265 on the USMLE Step 2 CK and actively engaging in research and leadership.

🩺 Professional Endeavors

Currently a Resident Physician in Diagnostic Radiology at Walter Reed National Military Medical Center (expected 2030), Dr. Hering is integrating rigorous clinical training with a robust military medical background. She has held numerous leadership positions—from Platoon Leader to President of Harvard’s Interventional Radiology Interest Group—reflecting a rare blend of military discipline and medical acumen. Her clinical and surgical experiences at institutions like Walter Reed, MGH, and BIDMC have laid a strong foundation for a future in academic and interventional radiology.

🔬 Contributions and Research Focus

Dr. Hering’s research spans vascular and interventional radiology, pulmonary arteriovenous malformations, trauma imaging, and military health, with over 20 peer-reviewed publications. She has contributed to top-tier journals including CHEST, Spine Journal, Journal of Vascular and Interventional Radiology, and Military Medicine. As an editor for the MGH “White Book”, she has also shaped essential medical manuals for house staff. Her passion for research was recognized early through internships and fellowships, including work on Lyme disease and steroid hormone physiology.

🏅 Accolades and Recognition

A decorated scholar and athlete, Dr. Hering has earned numerous honors including:
🏆 1897 Fellowship Awardee (Top national Phi Kappa Phi applicant)
🥇 Trainee Case Competition Winner, New England Society of Interventional Radiology
🏃‍♀️ Champion in multiple marathons and ultramarathons including the Candlelight 12-Hour and Spartan Race
🎖️ Excellence in Life Science Award, Brigadier General Ramsden Award, and LTC Boyd Harris Leadership Award at West Point
📚 Recognized by the West Point Superintendent for academic, military, and physical excellence

🌍 Impact and Influence

Dr. Hering is a changemaker in both academic medicine and military health systems. Her efforts to increase access and mentorship—such as developing shadowing programs, founding wellness initiatives, and mentoring underrepresented pre-med students—demonstrate her commitment to building inclusive, high-impact medical communities. Her involvement in the Society of Interventional Radiology, Excelsior Surgical Society, and Empower Conference reflects a strategic vision for the future of healthcare delivery, particularly in military and interventional contexts.

🔮 Legacy and Future Contributions

With a rare combination of military leadership, scientific rigor, and clinical excellence, Dr. Kalei Hering is poised to leave a lasting mark on the fields of interventional radiology, medical education, and military medicine. Her pursuit of innovative techniques, policy development, and mentorship ensures that her influence will be deeply felt across clinical, academic, and operational environments for years to come. As she advances through her residency and beyond, Dr. Hering stands as a beacon of resilience, intellect, and service in modern medicine.

Publications


📄 Post-Treatment Monitoring of Pulmonary Arteriovenous Malformations: Challenges and Approaches

  • Authors: Kalei Hering, Patrick Sutphin, Sanjeeva Kalva

  • Journal: CHEST

  • Year: 2025


📄 Embolization of a Bleeding Duodenal Arteriovenous Malformation with a Conformable Embolic Material (Obsidio): Case Report

  • Authors: Kalei Hering, Patrick Sutphin, Sanjeeva Kalva

  • Journal: Journal of Clinical Interventional Radiology ISVIR

  • Year: 2025


📄 Long-Term Quality of Life and Functional Outcomes After Management of Spinal Epidural Abscess

  • Authors:  Kalei Hering, Grace X. Xiong, Andrew Nguyen, Andrew J. Schoenfeld

  • Journal:  The Spine Journal

  • Year: 2024


📄 Health-Care Utilization and Expenditures Associated with Long-Term Treatment After Combat and Non-Combat-Related Orthopaedic Trauma

  • Authors: Kalei Hering, Miles W.A. Fisher, Michael K. Dalton, Andrew K. Simpson, Jamie Ye, Nishant Suneja, Zara Cooper, Tracey P. Koehlmoos, Andrew J. Schoenfeld

  • Journal: Journal of Bone and Joint Surgery

  • Year: 2022


 

Meilang Xue | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Meilang Xue | Medicine and Dentistry | Best Researcher Award

University of Sydney | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Assoc. Prof. Dr. Meilang Xue embarked on her academic journey with a strong passion for biomedical sciences. She earned her PhD from the University of New South Wales in 2002, laying the foundation for a distinguished career in molecular and cellular research. Her early academic years were marked by an inquisitive drive to uncover the intricate mechanisms of inflammatory and autoimmune diseases, setting the stage for groundbreaking discoveries in the field.

Professional Endeavors 🏢

Dr. Xue is currently the Head of the Sutton Arthritis Research Laboratory and the Chief Scientist of the A3BC Biobank at the Institute of Bone & Joint Research, Kolling Institute, University of Sydney. Since joining the Sutton Lab after her PhD, she has been instrumental in advancing the understanding of inflammatory and autoimmune diseases. Her leadership in these roles has facilitated significant research collaborations and the translation of scientific findings into potential therapeutic applications.

Contributions and Research Focus 🔬

Dr. Xue's research primarily explores the molecular and cellular mechanisms underpinning inflammatory and autoimmune conditions. She was the first to elucidate the critical role of the endothelial protein C receptor (EPCR) and its anti-clotting properties within the synovial joint and skin. These discoveries have revolutionized the understanding of rheumatoid arthritis, skin inflammation, and even type 1 diabetes. Her research has been widely recognized in high-impact journals such as Ann Rheum Dis, Arthritis Rheum, Rheumatology, and Journal of Investigative Dermatology. With 92 publications, 25 patents, and over 6,200 citations, her work has significantly contributed to medical science.

Accolades and Recognition 🏆

Dr. Xue's exemplary contributions have earned her numerous prestigious research fellowships and grants exceeding $5 million, funded by the NHMRC, Arthritis Australia, Lincoln Centre, JDRF International, and industry partners. She has been ranked as the 12th world-leading expert in endothelial protein C receptor research, placing her in the top 0.67% of published authors worldwide in this domain. Her h-index of 37 further underscores her influential impact on the field.

Impact and Influence 🌍

Beyond her research, Dr. Xue has played a crucial role in fostering the next generation of scientists. She has mentored and supervised numerous PhD candidates, postdoctoral fellows, honors students, and research assistants. As a committee member of the Kolling Institute’s Musculoskeletal Priority Research Area Leadership Group and the Kolling Research Enabler Group, she continues to shape the direction of musculoskeletal research. Additionally, her work with the A3BC as a Steering Committee member and chief scientist since 2017 has strengthened national and international research collaborations.

Legacy and Future Contributions 📚

Dr. Xue's dedication to scientific excellence ensures a lasting legacy in inflammatory and autoimmune disease research. Her ongoing studies into the protein C system’s role in disease modulation continue to inspire new therapeutic strategies. With her leadership in academia and industry collaborations, she is set to drive further advancements in precision medicine. Her unwavering commitment to research, mentorship, and innovation cements her reputation as a trailblazer in the field of molecular medicine.

Publications


  • 📄 Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis
    Author(s): Meilang Xue, Lyn March
    Journal: Cells
    Year: 2025


  • 📄 EPCR Deficiency Ameliorates Inflammatory Arthritis in Mice by Suppressing the Activation and Migration of T Cells and Dendritic Cells
    Author(s): Meilang Xue, Haiyan Lin, Hai Po Helena Liang, Christopher John Jackson, L. M. March
    Journal: Rheumatology (United Kingdom)
    Year: 2024


  • 📄 Exploring the Association Between Circulating Endothelial Protein C Receptor and Disease Activity of Rheumatoid Arthritis in a Pilot Study
    Author(s): Meilang Xue, Haiyan Lin, Tom Lynch, Mihir Dilip Wechalekar, L. M. March
    Journal: Rheumatology Advances in Practice
    Year: 2024


  • 📄 Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model
    Author(s): Meilang Xue, Christopher John Jackson, Haiyan Lin, John H. Griffin, L. M. March
    Journal: International Journal of Molecular Sciences
    Year: 2024


  • 📄 Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing
    Author(s): Sohel M. Julovi, Kelly J. McKelvey, Nikita Minhas, Meilang Xue, Christopher John Jackson
    Journal: International Journal of Molecular Sciences
    Year: 2024


 

Songhua Yan | Engineering | Best Researcher Award

Prof. Songhua Yan | Engineering | Best Researcher Award

Capital Medical University | China

Author Profile

Scopus

🎓 Early Academic Pursuits

Prof. Songhua Yan embarked on an academic journey in sports biomechanics at Beijing Sports University, where he obtained his B.S. in Exercise & Sports Science (1998). His passion for biomechanics led him to pursue an M.S. (2001) and a Ph.D. (2004) in Sports Biomechanics from the same institution. During these formative years, he cultivated a deep understanding of human movement, biomechanics, and rehabilitation, laying the groundwork for his future research and contributions.

🏅 Professional Endeavors

Prof. Yan has had an illustrious career in biomedical engineering and rehabilitation sciences. Since 2004, he has been a faculty member at the Biomedical Engineering School, Capital Medical University, Beijing. He served as an Assistant Professor from 2004 to 2009 and has been an Associate Professor since 2010. His commitment to advancing biomechanics and rehabilitation engineering was further enriched during his tenure as a visiting scholar in Motor Behavior at Peking University (2012–2013). His collaborations with hospitals and medical institutions have facilitated cutting-edge research in gait analysis and rehabilitation techniques.

🔬 Contributions and Research Focus

Prof. Yan's research is centered on the biomechanical characteristics of lower extremities, particularly in obese children, children with cerebral palsy, and patients with Knee Osteoarthritis (KOA). His expertise includes gait analysis, knee proprioception, neuromuscular control, and rehabilitation engineering. He employs advanced biomechanical methods, such as kinematics, kinetics, electromyography (EMG), and electroencephalography (EEG), to evaluate and improve movement function. His research has led to groundbreaking studies on knee joint replacement surgeries, gait abnormalities, and balance control. He has spearheaded multiple national and provincial research projects, receiving prestigious funding, including the Top Young Talents Cultivation Program of Beijing Municipal Universities.

🏆 Accolades and Recognition

Prof. Yan has gained significant recognition for his contributions to biomechanics and rehabilitation. He is an esteemed member of the Rehabilitation Engineering Professional Committee of the Beijing Rehabilitation Medicine Association and the Elderly Health Management Branch of the Beijing Health Management Association. Additionally, he serves as an editorial board member for the Journal of Medical Biomechanics, contributing to the dissemination of pioneering research in the field.

🌍 Impact and Influence

With a prolific publication record of over 60 academic papers in leading international and domestic journals, Prof. Yan has significantly influenced the field of biomechanics and rehabilitation engineering. His expertise has been instrumental in advancing gait analysis techniques, understanding movement disorders, and developing innovative rehabilitation strategies. His research on knee osteoarthritis and prosthetic designs has directly impacted clinical practices, enhancing the quality of life for patients.

🔮 Legacy and Future Contributions

Prof. Yan continues to shape the future of biomechanics and rehabilitation engineering through ongoing research and mentorship. His dedication to advancing gait analysis, proprioception studies, and rehabilitation robotics is paving the way for innovative therapeutic interventions. His legacy lies in his unwavering commitment to improving mobility and rehabilitation outcomes for individuals with movement disorders. As he continues to lead pioneering research, his contributions will leave a lasting imprint on the fields of sports biomechanics, prosthetics, and rehabilitation medicine.

 

Publications


📄 Short-term Effect of Unicompartmental Knee Arthroplasty on Muscle Coordination in Patients with Knee Osteoarthritis
Author: Zhixin Jin, Jingnan Shi, Haohua Zhang, Kuan Zhang, Xinglong Zhou, Songhua Yan
Journal: Clinical Biomechanics
Year: 2025


📄 Effects of Total Knee Arthroplasty on Proprioception in Patients with Knee Osteoarthritis
Author: Zhang Quan, Shi Jingnan, Zhang Kuan, Zhang Haohua, Yan Songhua
Journal: Journal of Medical Biomechanics
Year: 2024


📄 The Effect of Thigh Muscle Forces on Knee Contact Force in Female Patients with Severe Knee Osteoarthritis
Author: Liu Tingting, Xie Hao, Yan Songhua, Zeng Jizhou, Zhang Kuan
Journal: Bioengineering
Year: 2024


📄 Effects of Total Knee Arthroplasty on Proprioception in Patients with Knee Osteoarthritis
Author: Zhang Quan, Shi Jingnan, Zhang Kuan, Zhang Haohua, Yan Songhua
Journal: Yiyong Shengwu Lixue/Journal of Medical Biomechanics
Year: 2024


📄 Dynamic Electromyography Findings of the Lower Leg Muscles During Walking in Spastic Cerebral Palsy Children with Hindfoot Valgus
Author: Xuesen Wang, Xiaohu Fu, Wei Li, Qining Wang, Kuan Zhang, Songhua Yan
Journal: Clinical Biomechanics
Year: 2023


Jeong A Kim | Medicine and Dentistry | Best Researcher Award

Prof. Jeong A Kim | Medicine and Dentistry | Best Researcher Award

St. Vincent Hospital, The Catholic University of Korea | South Korea

Author Profile

Scopus

Early Academic Pursuits ✨

Prof. Jeong A Kim embarked on an illustrious academic journey in the field of medicine, laying a solid foundation at the Catholic University Medical College. She completed her premedical course in 1986, followed by earning her Doctor of Medicine degree in 1990. Her passion for internal medicine and hematology led her to pursue advanced studies at The Catholic University of Korea, where she obtained a Master’s degree in 1998 and a Ph.D. in 2001. This strong academic background established her as a dedicated scholar committed to the advancement of medical sciences.

Professional Endeavors 🏥

Prof. Kim's professional career began with rigorous postdoctoral training. She completed her internship at St. Mary’s Hospital in 1991, followed by a residency in Internal Medicine at Catholic University Medical College until 1995. She further honed her expertise in hemato-oncology through a fellowship at Samsung Medical Center. Her international exposure expanded when she joined the Department of Microbiology and Immunology at IUPUI, USA, as a postdoctoral researcher. Her academic appointments at The Catholic University of Korea saw a steady rise, from Instructor in 1997 to Assistant Professor in 2001, Associate Professor in 2009, and finally attaining the prestigious title of Professor of Internal Medicine in 2014. In parallel, she has been a dedicated physician at St. Vincent Hospital since 1997 and has been leading the hematology and stem cell transplantation center since 2018.

Contributions and Research Focus 📝

Prof. Kim has made groundbreaking contributions in hematology and oncology, with a primary focus on stem cell transplantation, multiple myeloma, and lymphoma. Her extensive clinical trials and research studies have played a pivotal role in developing new treatment modalities for hematologic malignancies. Her work in targeted therapies, chemotherapy combinations, and immunotherapy has significantly improved patient outcomes and quality of life. She has been involved in more than 60 clinical trials, evaluating novel drug efficacy and safety, including studies on Zoledronic acid for multiple myeloma, targeted treatments like Dasatinib for leukemia, and the role of rituximab in lymphoma. Her research has also delved into prognostic factors, precision medicine, and innovative therapeutic strategies for refractory and relapsed hematologic diseases.

Accolades and Recognition 🏆

Prof. Kim's relentless pursuit of excellence has earned her recognition from esteemed medical institutions and societies. As a member of the Korean Association of Internal Medicine, the Korean Hematology Association, and the American Hematology Association, she has played an instrumental role in shaping global hematologic research. Her contributions have been acknowledged through numerous awards, invitations as a keynote speaker, and influential publications in high-impact medical journals.

Impact and Influence ✨

With a career spanning decades, Prof. Kim has mentored numerous young medical professionals, guiding them in clinical research and evidence-based medical practice. Her work has directly influenced hematologic treatment protocols in Korea and internationally. Her leadership in hematology and stem cell transplantation has set new benchmarks in patient care and innovative treatment approaches.

Legacy and Future Contributions 🌟

Prof. Jeong A Kim's legacy is deeply ingrained in the advancements of hematology and oncology. Her dedication to research, patient care, and education continues to inspire the next generation of medical professionals. Looking ahead, she remains committed to pioneering more targeted therapies, enhancing stem cell transplantation techniques, and improving long-term survival rates for hematologic malignancy patients. With ongoing research and collaborations, she is poised to make even greater strides in the field, leaving an indelible mark on medical science and patient care.

 

Publications


📄 The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma
Authors: H. Cho, J. Kim, Y. Park, Y. Kim, J. Kim, Jeong-ah
Journal: Leukemia Research
Year: 2025


📄 Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Authors: N.L. Bartlett, U.H. Hahn, W. Kim, F. Jie, J. Kim, Jeong-ah
Journal: Journal of Clinical Oncology
Year: 2025


📄 Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Authors: D. Shin, S. Park, E. Jang, W. Lee, D. Kim
Journal: Leukemia Research
Year: 2024


📄 Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Authors: H.Y. Yhim, Y. Park, J. Kim, Jeong-ah, D. Yang, J. Kwak
Journal: The Korean Journal of Internal Medicine
Year: 2024


Dan Liu | Medicine and Dentistry | Best Researcher Award

Dr. Dan Liu | Medicine and Dentistry | Best Researcher Award

General Hospital of Ningxia Medical University | China

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Dan Liu began her distinguished journey with a strong foundation in medicine and research. Her academic rigor led her to advanced positions, including her role as a doctoral supervisor and principal investigator. She gained international exposure as a visiting scholar at the University of Iowa and Texas Medical Center, further enhancing her global perspective and expertise in medical sciences.

💼 Professional Endeavors

Currently, Dr. Liu serves as the director of the Ningxia Hysteroscopy Diagnosis and Treatment Center and plays a pivotal role at the General Hospital of Ningxia Medical University. Her leadership in hysteroscopy diagnostics has transformed the medical landscape in Ningxia. Beyond clinical duties, she actively drives innovation and research, influencing medical sciences both regionally and nationally.

🔬 Contributions and Research Focus

Dr. Liu's research portfolio is impressive, including two projects funded by the National Natural Science Foundation of China and one significant national-grade project. She has successfully integrated technological advancements into her field, holding one utility model patent and one invention patent. Her pioneering contributions address critical challenges in women’s health, making significant strides in hysteroscopy techniques and diagnostics.

🏆 Accolades and Recognition

Dr. Liu’s accomplishments have garnered numerous awards, such as the prestigious second prize of the Science and Technology Progress Award of Ningxia Autonomous Region. In 2023, her dedication and exceptional service earned her the "Special Contribution" Award from People’s Daily Online, recognizing her as an excellent doctor. These accolades underscore her impact on medical innovation and patient care.

🌟 Impact and Influence

Through her dual roles in clinical practice and academia, Dr. Liu has shaped the next generation of medical professionals while advancing the field of hysteroscopy. Her leadership in research and treatment has set new benchmarks, directly benefiting patients and fostering a culture of innovation in the medical community.

🔮 Legacy and Future Contributions

As a trailblazer in her field, Dr. Liu’s legacy is one of excellence and commitment to advancing healthcare. Her ongoing projects and visionary leadership promise continued contributions to medical science, inspiring future researchers and clinicians to follow her path of innovation and service.

 

Publications


📝 Meta-analysis of FOXP3 polymorphisms and recurrent spontaneous abortion susceptibility
Authors: Shuai, R., Li, D., Xu, X., Yang, X., Liu, D.
Journal: American Journal of Reproductive Immunology
Year: 2024


📝 The osteogenesis and the biologic mechanism of thermo-responsive injectable hydrogel containing carboxymethyl chitosan/sodium alginate nanoparticles towards promoting osteal wound healing
Authors: Shi, Z., Yang, F., Pang, Q., Zhu, Y.
Journal: International Journal of Biological Macromolecules
Year: 2023


📝 Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathway
Authors: Yuan, L., Cao, J., Hu, M., Chen, M., Liu, D.
Journal: Reproductive Biology and Endocrinology
Year: 2022


📝 A novel intrauterine barrier for preventing the recurrence of IUA after TCRA procedure
Authors: Chen, M., Yuan, L., Jin, H., Zhang, X., Liu, D.
Journal: Medical Hypotheses
Year: 2022


📝 Organoid Transplantation Can Improve Reproductive Prognosis by Promoting Endometrial Repair in Mice
Authors: Zhang, H., Xu, D., Li, Y., Li, G., Liu, D.
Journal: International Journal of Biological Sciences
Year: 2022